𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of Enzyme Inhibitors in Drug Discovery. By Robert A. Copeland.

✍ Scribed by Rolf Breinbauer

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
73 KB
Volume
44
Category
Article
ISSN
0044-8249

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

De Novo Design, Synthesis, and In Vitro
De Novo Design, Synthesis, and In Vitro Evaluation of a New Class of Nonpeptidic Inhibitors of the Malarial Enzyme Plasmepsin II
✍ David A. Carcache; Simone R. Hörtner; Andreas Bertogg; Christoph Binkert; Daniel 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 2 views

Malaria, a life-threatening disease caused by parasites of the genus Plasmodium, affects 500 million people annually, of which more than one million die. [1] The emergence of multi-drugresistant strains of Plasmodium falciparum, the parasite that causes the deadliest form of malaria, exacerbates the

Drug Delivery by an Enzyme-Mediated Cycl
Drug Delivery by an Enzyme-Mediated Cyclization of a Lipid Prodrug with Unique Bilayer-Formation Properties
✍ Lars Linderoth; Günther H. Peters; Robert Madsen; Thomas L. Andresen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB

## Abstract **Special delivery**: Liposomal drug‐delivery systems in which prodrugs are activated specifically by disease‐associated enzymes have great potential for the treatment of severe diseases, such as cancer. A new type of phospholipid‐based prodrug has the ability to form stable small unila